[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

2017-2022 Global and Japan Natural Source Antitumor Medicine Market Analysis Report

August 2017 | 105 pages | ID: 23CC559E906EN
JP Research

US$ 3,085.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Natural Source Antitumor Medicine market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022.

Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%.

This report, with focus on top players in the global and Japan, studies the Natural Source Antitumor Medicine market's development status and future trend in the global and Japan. It splits Natural Source Antitumor Medicine market by type and by applications to fully and deeply research and reveal market profile and prospect.

The major players include
  • NIPPON KAYAKU
  • Bristol-Myers Squibb
  • Elmed Eisai Co., Ltd.
  • Nichi-iko Pharmaceutical Co.,Ltd
  • TAKATA SEIYAKU Co., Ltd.
  • TOWA PHARMACEUTICAL CO., LTD.
  • Yakult Honsha Co., Ltd.
  • ...
Geographically, this report splits the Global market into the following regions:
  • Asia Pacific
    • Japan
      • Tokyo
      • Yokohama
      • Osaka
      • Nagoya
      • Others
    • China
    • Korea
    • India
    • Others
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Russia
    • Others
  • North America
    • United States
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Southeast Asia
    • Singapore
    • Malaysia
    • Vietnam
    • Myanmar
    • Thailand
    • Indonesia
    • Philippines
    • Others
  • Middle East & Africa
    • Saudi Arabia
    • Iran
    • UAE
    • Turkey
    • Israel
    • Egypt
    • South Africa
    • Others
On the basis of product, the Natural Source Antitumor Medicine market is primarily split into

Natural Source Antitumor Medicine Market, by Natural Source
  • Topotecan
  • Camptothecin
  • Rubitecan
  • Paclitaxel
  • Colchicine
  • Etoposide
  • Docetaxel
  • Resveratrol
  • Podophyllotoxin
  • Irinotecan
  • Cantharidin
  • Harringtonolide
  • Vinblastine
  • Epothilone
Key Applications
  • Department of Oncology
  • Department of Chemotherapy
  • Pharmacology
1 NATURAL SOURCE ANTITUMOR MEDICINE OVERVIEW

1.1 Product Overview and Scope of Natural Source Antitumor Medicine
1.2 Global and Japan Natural Source Antitumor Medicine Market by Applications/End Users
  1.2.1 Japan Natural Source Antitumor Medicine Sales () and Market Share Comparison by Applications (2012-2017)
    1.2.1.1 Japan Natural Source Antitumor Medicine Sales () and Market Share by Applications (2012-2017)
    1.2.1.2 Japan Natural Source Antitumor Medicine Sales Growth Rate (%) by Applications (2012-2017)
    1.2.1.3 Market Drivers and Opportunities
  1.2.2 Japan Natural Source Antitumor Medicine Sales () and Market Share Comparison by Applications (2012-2017)
  1.2.3 Global Natural Source Antitumor Medicine Sales by Application (2012-2017)
    1.2.3.1 Global Natural Source Antitumor Medicine Sales () and Market Share by Applications (2012-2017)
    1.2.3.2 Global Natural Source Antitumor Medicine Sales Growth Rate (%) by Applications (2012-2017)
    1.2.3.3 Market Drivers and Opportunities
  1.2.4 Global Natural Source Antitumor Medicine Sales () and Market Share Comparison by Applications (2012-2017)
  1.2.5 Department of Oncology
  1.2.6 Department of Chemotherapy
  1.2.7 Pharmacology
1.3 Global and Japan Market Size (Sales and Revenue) of Natural Source Antitumor Medicine (2012-2017)
  1.3.1 Japan Market Size (Sales and Revenue) of Natural Source Antitumor Medicine (2012-2017)
    1.3.1.1 Japan Natural Source Antitumor Medicine Sales () and Growth Rate (%) (2012-2017)
    1.3.1.2 Japan Natural Source Antitumor Medicine Revenue (Million USD) and Growth Rate (2012-2017)
  1.3.2 Global Market Size (Sales and Revenue) of Natural Source Antitumor Medicine (2012-2017)
    1.3.2.1 Global Natural Source Antitumor Medicine Sales () and Growth Rate (%) (2012-2017)
    1.3.2.2 Global Natural Source Antitumor Medicine Revenue (Million USD) and Growth Rate (2012-2017)
1.4 Global and Japan Classification of Natural Source Antitumor Medicine by Natural Source
  1.4.1 Japan Natural Source Antitumor Medicine Sales () and Market Share by Natural Source (2012-2017)
  1.4.2 Global Natural Source Antitumor Medicine Sales () and Market Share by Natural Source (2012-2017)
  1.4.3 Japan Natural Source Antitumor Medicine Revenue (Million USD) and Market Share by Natural Source (2012-2017)
  1.4.4 Global Natural Source Antitumor Medicine Revenue (Million USD) and Market Share by Natural Source (2012-2017)
  1.4.5 Japan Natural Source Antitumor Medicine Price () by Natural Source (2012-2017)
  1.4.6 Global Natural Source Antitumor Medicine Price () by Natural Source (2012-2017)
  1.4.7 Japan Natural Source Antitumor Medicine Sales Growth Rate (%) by Natural Source (2012-2017)
  1.4.8 Global Natural Source Antitumor Medicine Sales Growth Rate (%) by Natural Source (2012-2017)
  1.4.9 Topotecan
  1.4.10 Camptothecin
  1.4.11 Rubitecan
  1.4.12 Paclitaxel
  1.4.13 Colchicine
Etoposide
Docetaxel
Resveratrol
Podophyllotoxin
Irinotecan
Cantharidin
Harringtonolide
Vinblastine
Epothilone

2 GLOBAL AND JAPAN NATURAL SOURCE ANTITUMOR MEDICINE MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 Japan Natural Source Antitumor Medicine Market Competition by Players/Manufacturers
  2.1.1 Japan Natural Source Antitumor Medicine Sales and Market Share of Key Players/Manufacturers (2012-2017)
  2.1.2 Japan Natural Source Antitumor Medicine Revenue and Share by Players/Manufacturers (2012-2017)
  2.1.3 Japan Natural Source Antitumor Medicine Average Price () by Players/Manufacturers (2012-2017)
  2.1.4 Japan Natural Source Antitumor Medicine Market Competitive Situation and Trends
    2.1.4.1 Japan Natural Source Antitumor Medicine Market Concentration Rate
    2.1.4.2 Japan Natural Source Antitumor Medicine Market Share of Top 3 and Top 5 Players/Manufacturers
    2.1.4.3 Mergers & Acquisitions, Expansion in Japan Market
  2.1.5 Japan Players/Manufacturers Natural Source Antitumor Medicine Manufacturing Base Distribution, Sales Area, Product Types
2.2 Global Natural Source Antitumor Medicine Market Competition by Players/Manufacturers
  2.2.1 Global Natural Source Antitumor Medicine Sales and Market Share of Key Players/Manufacturers (2012-2017)
  2.2.2 Global Natural Source Antitumor Medicine Revenue and Share by Players/Manufacturers (2012-2017)
  2.2.3 Global Natural Source Antitumor Medicine Average Price () by Players/Manufacturers (2012-2017)
  2.2.4 Global Natural Source Antitumor Medicine Market Competitive Situation and Trends
    2.2.4.1 Global Natural Source Antitumor Medicine Market Concentration Rate
    2.2.4.2 Global Natural Source Antitumor Medicine Market Share of Top 3 and Top 5 Players/Manufacturers
    2.2.4.3 Mergers & Acquisitions, Expansion in Global Market
  2.2.5 Global Players/Manufacturers Natural Source Antitumor Medicine Manufacturing Base Distribution, Sales Area, Product Types

3 GLOBAL AND JAPAN NATURAL SOURCE ANTITUMOR MEDICINE SALES AND REVENUE BY REGIONS (2012-2017)

3.1 Asia Pacific Natural Source Antitumor Medicine Sales and Revenue by Regions (2012-2017)
  3.1.1 Japan Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.1.1.1 Japan Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.1.1.2 Japan Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.1.1.3 Japan Natural Source Antitumor Medicine Price ()(2012-2017)
  3.1.2 China Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.1.2.1 China Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.1.2.2 China Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.1.2.3 China Natural Source Antitumor Medicine Price ()(2012-2017)
  3.1.3 Korea Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.1.3.1 Korea Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.1.3.2 Korea Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.1.3.3 Korea Natural Source Antitumor Medicine Price ()(2012-2017)
  3.1.4 India Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.1.4.1 India Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.1.4.2 India Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.1.4.3 India Natural Source Antitumor Medicine Price ()(2012-2017)
  3.1.5 Others Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.1.5.1 Others Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.1.5.2 Others Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.1.5.3 Others Natural Source Antitumor Medicine Price ()(2012-2017)
3.2 Europe Natural Source Antitumor Medicine Sales and Revenue by Regions (2012-2017)
  3.2.1 France Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.2.1.1 France Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.2.1.2 France Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.2.1.3 France Natural Source Antitumor Medicine Price ()(2012-2017)
  3.2.2 Germany Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.2.2.1 Germany Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.2.2.2 Germany Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.2.2.3 Germany Natural Source Antitumor Medicine Price ()(2012-2017)
  3.2.3 United Kingdom Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.2.3.1 United Kingdom Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.2.3.2 United Kingdom Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.2.3.3 United Kingdom Natural Source Antitumor Medicine Price ()(2012-2017)
  3.2.4 Italy Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.2.4.1 Italy Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.2.4.2 Italy Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.2.4.3 Italy Natural Source Antitumor Medicine Price ()(2012-2017)
  3.2.5 Russia Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.2.5.1 Russia Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.2.5.2 Russia Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.2.5.3 Russia Natural Source Antitumor Medicine Price ()(2012-2017)
  3.2.6 Others Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.2.6.1 Others Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.2.6.2 Others Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.2.6.3 Others Natural Source Antitumor Medicine Price ()(2012-2017)
3.3 North America Natural Source Antitumor Medicine Sales and Revenue by Regions (2012-2017)
  3.3.1 United States Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.3.1.1 United States Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.3.1.2 United States Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.3.1.3 United States Natural Source Antitumor Medicine Price ()(2012-2017)
  3.3.2 Canada Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.3.2.1 Canada Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.3.2.2 Canada Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.3.2.3 Canada Natural Source Antitumor Medicine Price ()(2012-2017)
3.4 Latin America Natural Source Antitumor Medicine Sales and Revenue by Regions (2012-2017)
  3.4.1 Brazil Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.4.1.1 Brazil Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.4.1.2 Brazil Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.4.1.3 Brazil Natural Source Antitumor Medicine Price ()(2012-2017)
  3.4.2 Mexico Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.4.2.1 Mexico Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.4.2.2 Mexico Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.4.2.3 Mexico Natural Source Antitumor Medicine Price ()(2012-2017)
  3.4.3 Others Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.4.3.1 Others Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.4.3.2 Others Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.4.3.3 Others Natural Source Antitumor Medicine Price ()(2012-2017)
3.5 Southeast Asia Natural Source Antitumor Medicine Sales and Revenue by Regions (2012-2017)
  3.5.1 Singapore Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.5.1.1 Singapore Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.5.1.2 Singapore Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.5.1.3 Singapore Natural Source Antitumor Medicine Price ()(2012-2017)
  3.5.2 Malaysia Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.5.2.1 Malaysia Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.5.2.2 Malaysia Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.5.2.3 Malaysia Natural Source Antitumor Medicine Price ()(2012-2017)
  3.5.3 Vietnam Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.5.3.1 Vietnam Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.5.3.2 Vietnam Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.5.3.3 Vietnam Natural Source Antitumor Medicine Price ()(2012-2017)
  3.5.4 Myanmar Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.5.4.1 Myanmar Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.5.4.2 Myanmar Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.5.4.3 Myanmar Natural Source Antitumor Medicine Price ()(2012-2017)
  3.5.5 Thailand Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.5.5.1 Thailand Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.5.5.2 Thailand Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.5.5.3 Thailand Natural Source Antitumor Medicine Price ()(2012-2017)
  3.5.6 Indonesia Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.5.6.1 Indonesia Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.5.6.2 Indonesia Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.5.6.3 Indonesia Natural Source Antitumor Medicine Price ()(2012-2017)
  3.5.7 Philippines Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.5.7.1 Philippines Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.5.7.2 Philippines Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.5.7.3 Philippines Natural Source Antitumor Medicine Price ()(2012-2017)
  3.5.8 Others Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.5.8.1 Others Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.5.8.2 Others Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.5.8.3 Others Natural Source Antitumor Medicine Price ()(2012-2017)
3.6 Middle East & Africa Natural Source Antitumor Medicine Sales and Revenue by Regions (2012-2017)
  3.6.1 Saudi Arabia Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.6.1.1 Saudi Arabia Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.6.1.2 Saudi Arabia Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.6.1.3 Saudi Arabia Natural Source Antitumor Medicine Price ()(2012-2017)
  3.6.2 Iran Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.6.2.1 Iran Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.6.2.2 Iran Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.6.2.3 Iran Natural Source Antitumor Medicine Price ()(2012-2017)
  3.6.3 UAE Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.6.3.1 UAE Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.6.3.2 UAE Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.6.3.3 UAE Natural Source Antitumor Medicine Price ()(2012-2017)
  3.6.4 Turkey Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.6.4.1 Turkey Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.6.4.2 Turkey Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.6.4.3 Turkey Natural Source Antitumor Medicine Price ()(2012-2017)
  3.6.5 Israel Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.6.5.1 Israel Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.6.5.2 Israel Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.6.5.3 Israel Natural Source Antitumor Medicine Price ()(2012-2017)
  3.6.6 Egypt Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.6.6.1 Egypt Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.6.6.2 Egypt Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.6.6.3 Egypt Natural Source Antitumor Medicine Price ()(2012-2017)
  3.6.7 South Africa Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.6.7.1 South Africa Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.6.7.2 South Africa Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.6.7.3 South Africa Natural Source Antitumor Medicine Price ()(2012-2017)
  3.6.8 Others Natural Source Antitumor Medicine Sales and Revenue (2012-2017)
    3.6.8.1 Others Natural Source Antitumor Medicine Sales () and Market Share (2012-2017)
    3.6.8.2 Others Natural Source Antitumor Medicine Revenue (Million USD) and Market Share (2012-2017)
    3.6.8.3 Others Natural Source Antitumor Medicine Price ()(2012-2017)

4 GLOBAL AND JAPAN NATURAL SOURCE ANTITUMOR MEDICINE PLAYERS/MANUFACTURERS PROFILES AND SALES DATA

4.1 NIPPON KAYAKU
  4.1.1 Company Basic Information, Manufacturing Base and Competitors
  4.1.2 Natural Source Antitumor Medicine Product Category, Application and Specification
    4.1.2.1 Product A
    4.1.2.2 Product B
  4.1.3 NIPPON KAYAKU Natural Source Antitumor Medicine Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.1.4 Main Business/Business Overview
4.2 Bristol-Myers Squibb
  4.2.1 Company Basic Information, Manufacturing Base and Competitors
  4.2.2 Natural Source Antitumor Medicine Product Category, Application and Specification
    4.2.2.1 Product A
    4.2.2.2 Product B
  4.2.3 Bristol-Myers Squibb Natural Source Antitumor Medicine Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.2.4 Main Business/Business Overview
4.3 Elmed Eisai Co., Ltd.
  4.3.1 Company Basic Information, Manufacturing Base and Competitors
  4.3.2 Natural Source Antitumor Medicine Product Category, Application and Specification
    4.3.2.1 Product A
    4.3.2.2 Product B
  4.3.3 Elmed Eisai Co., Ltd. Natural Source Antitumor Medicine Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.3.4 Main Business/Business Overview
4.4 Nichi-iko Pharmaceutical Co.,Ltd
  4.4.1 Company Basic Information, Manufacturing Base and Competitors
  4.4.2 Natural Source Antitumor Medicine Product Category, Application and Specification
    4.4.2.1 Product A
    4.4.2.2 Product B
  4.4.3 Nichi-iko Pharmaceutical Co.,Ltd Natural Source Antitumor Medicine Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.4.4 Main Business/Business Overview
4.5 TAKATA SEIYAKU Co., Ltd.
  4.5.1 Company Basic Information, Manufacturing Base and Competitors
  4.5.2 Natural Source Antitumor Medicine Product Category, Application and Specification
    4.5.2.1 Product A
    4.5.2.2 Product B
  4.5.3 TAKATA SEIYAKU Co., Ltd. Natural Source Antitumor Medicine Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.5.4 Main Business/Business Overview
4.6 TOWA PHARMACEUTICAL CO., LTD.
  4.6.1 Company Basic Information, Manufacturing Base and Competitors
  4.6.2 Natural Source Antitumor Medicine Product Category, Application and Specification
    4.6.2.1 Product A
    4.6.2.2 Product B
  4.6.3 TOWA PHARMACEUTICAL CO., LTD. Natural Source Antitumor Medicine Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.6.4 Main Business/Business Overview
4.7 Yakult Honsha Co., Ltd.
  4.7.1 Company Basic Information, Manufacturing Base and Competitors
  4.7.2 Natural Source Antitumor Medicine Product Category, Application and Specification
    4.7.2.1 Product A
    4.7.2.2 Product B
  4.7.3 Yakult Honsha Co., Ltd. Natural Source Antitumor Medicine Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.7.4 Main Business/Business Overview

...

5 NATURAL SOURCE ANTITUMOR MEDICINE MANUFACTURING COST ANALYSIS

5.1 Natural Source Antitumor Medicine Key Raw Materials Analysis
  5.1.1 Key Raw Materials
  5.1.2 Price Trend of Key Raw Materials
  5.1.3 Key Suppliers of Raw Materials
  5.1.4 Market Concentration Rate of Raw Materials
5.2 Proportion of Manufacturing Cost Structure
  5.2.1 Raw Materials
  5.2.2 Labor Cost
  5.2.3 Manufacturing Expenses
5.3 Manufacturing Process Analysis of Natural Source Antitumor Medicine

6 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

6.1 Natural Source Antitumor Medicine Industrial Chain Analysis
6.2 Upstream Raw Materials Sourcing
6.3 Raw Materials Sources of Natural Source Antitumor Medicine Major Players/Manufacturers in 2016
6.4 Downstream Buyers

7 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

7.1 Marketing Channel
  7.1.1 Direct Marketing
  7.1.2 Indirect Marketing
  7.1.3 Marketing Channel Development Trend
7.2 Market Positioning
  7.2.1 Pricing Strategy
  7.2.2 Brand Strategy
  7.2.3 Target Client
7.3 Distributors/Traders List

8 MARKET EFFECT FACTORS ANALYSIS

8.1 Technology Progress/Risk
  8.1.1 Substitutes Threat
  8.1.2 Technology Progress in Related Industry
8.2 Consumer Needs/Customer Preference Change
8.3 Economic/Political Environmental Change

9 GLOBAL AND JAPAN NATURAL SOURCE ANTITUMOR MEDICINE MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

9.1 Global and Japan Natural Source Antitumor Medicine Sales (), Revenue (Million USD) Forecast (2017-2022)
9.2 Global and Japan Natural Source Antitumor Medicine Sales () Forecast by Type (2017-2022)
  9.2.1 by Natural Source
  9.2.2 by
9.3 Global and Japan Natural Source Antitumor Medicine Sales () Forecast by Application (2017-2022)
9.4 Global and Japan Natural Source Antitumor Medicine Sales () Forecast by Regions (2017-2022)

10 RESEARCH FINDINGS AND CONCLUSION

11 METHODOLOGY AND DATA SOURCE

11.1 Methodology/Research Approach
  11.1.1 Research Programs/Design
  11.1.2 Market Size Estimation
  11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
  11.2.1 Secondary Sources
  11.2.2 Primary Sources
11.3 Disclaimer
11.4 Author List
LIST OF TABLES AND FIGURES

Figure Product Picture of Natural Source Antitumor Medicine
Table Japan Natural Source Antitumor Medicine Sales (Million Units) Comparison by Applications (2012-2017)
Figure Japan Sales Market Share (%) of Natural Source Antitumor Medicine by Applications in 2016
Table Global Natural Source Antitumor Medicine Sales (Million Units) Comparison by Applications (2012-2017)
Figure Global Sales Market Share (%) of Natural Source Antitumor Medicine by Applications in 2016
Figure Department of Oncology Examples
Table Key Downstream Customer in Department of Oncology
Figure Department of Chemotherapy Examples
Table Key Downstream Customer in Department of Chemotherapy
Figure Pharmacology Examples
Table Key Downstream Customer in Pharmacology
Figure Topotecan Product Picture
Figure Camptothecin Product Picture
Figure Rubitecan Product Picture
Figure Paclitaxel Product Picture
Figure Colchicine Product Picture
Figure Product Picture
Figure Product Picture
Table NIPPON KAYAKU Basic Information List
Table NIPPON KAYAKU Natural Source Antitumor Medicine Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table NIPPON KAYAKU Natural Source Antitumor Medicine Sales Growth Rate (%)(2012-2017)
Table NIPPON KAYAKU Natural Source Antitumor Medicine Sales Market Share (%) in Japan (2012-2017)
Figure NIPPON KAYAKU Natural Source Antitumor Medicine Revenue Market Share (%) in Japan (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Natural Source Antitumor Medicine Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table Bristol-Myers Squibb Natural Source Antitumor Medicine Sales Growth Rate (%)(2012-2017)
Table Bristol-Myers Squibb Natural Source Antitumor Medicine Sales Market Share (%) in Japan (2012-2017)
Figure Bristol-Myers Squibb Natural Source Antitumor Medicine Revenue Market Share (%) in Japan (2012-2017)
Table Elmed Eisai Co., Ltd. Basic Information List
Table Elmed Eisai Co., Ltd. Natural Source Antitumor Medicine Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table Elmed Eisai Co., Ltd. Natural Source Antitumor Medicine Sales Growth Rate (%)(2012-2017)
Table Elmed Eisai Co., Ltd. Natural Source Antitumor Medicine Sales Market Share (%) in Japan (2012-2017)
Figure Elmed Eisai Co., Ltd. Natural Source Antitumor Medicine Revenue Market Share (%) in Japan (2012-2017)
Table Nichi-iko Pharmaceutical Co.,Ltd Basic Information List
Table Nichi-iko Pharmaceutical Co.,Ltd Natural Source Antitumor Medicine Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table Nichi-iko Pharmaceutical Co.,Ltd Natural Source Antitumor Medicine Sales Growth Rate (%)(2012-2017)
Table Nichi-iko Pharmaceutical Co.,Ltd Natural Source Antitumor Medicine Sales Market Share (%) in Japan (2012-2017)
Figure Nichi-iko Pharmaceutical Co.,Ltd Natural Source Antitumor Medicine Revenue Market Share (%) in Japan (2012-2017)
Table TAKATA SEIYAKU Co., Ltd. Basic Information List
Table TAKATA SEIYAKU Co., Ltd. Natural Source Antitumor Medicine Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table TAKATA SEIYAKU Co., Ltd. Natural Source Antitumor Medicine Sales Growth Rate (%)(2012-2017)
Table TAKATA SEIYAKU Co., Ltd. Natural Source Antitumor Medicine Sales Market Share (%) in Japan (2012-2017)
Figure TAKATA SEIYAKU Co., Ltd. Natural Source Antitumor Medicine Revenue Market Share (%) in Japan (2012-2017)
Table TOWA PHARMACEUTICAL CO., LTD. Basic Information List
Table TOWA PHARMACEUTICAL CO., LTD. Natural Source Antitumor Medicine Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table TOWA PHARMACEUTICAL CO., LTD. Natural Source Antitumor Medicine Sales Growth Rate (%)(2012-2017)
Table TOWA PHARMACEUTICAL CO., LTD. Natural Source Antitumor Medicine Sales Market Share (%) in Japan (2012-2017)
Figure TOWA PHARMACEUTICAL CO., LTD. Natural Source Antitumor Medicine Revenue Market Share (%) in Japan (2012-2017)
Table Yakult Honsha Co., Ltd. Basic Information List
Table Yakult Honsha Co., Ltd. Natural Source Antitumor Medicine Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table Yakult Honsha Co., Ltd. Natural Source Antitumor Medicine Sales Growth Rate (%)(2012-2017)
Table Yakult Honsha Co., Ltd. Natural Source Antitumor Medicine Sales Market Share (%) in Japan (2012-2017)
Figure Yakult Honsha Co., Ltd. Natural Source Antitumor Medicine Revenue Market Share (%) in Japan (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Natural Source Antitumor Medicine
Figure Manufacturing Process Analysis of Natural Source Antitumor Medicine
Figure Natural Source Antitumor Medicine Industrial Chain Analysis
Table Raw Materials Sources of Natural Source Antitumor Medicine Major Players/Manufacturers in 2016
Table Major Buyers of Natural Source Antitumor Medicine
Table Distributors/Traders List
Figure Japan Natural Source Antitumor Medicine Sales () and Growth Rate (%) Forecast (2017-2022)
Figure Japan Natural Source Antitumor Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Natural Source Antitumor Medicine Price () Trend Forecast (2017-2022)
Figure Global Natural Source Antitumor Medicine Sales () and Growth Rate (%) Forecast (2017-2022)
Figure Global Natural Source Antitumor Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Natural Source Antitumor Medicine Price () Trend Forecast (2017-2022)
Table Japan Natural Source Antitumor Medicine Sales () Forecast by Type (2017-2022)
Table Global Natural Source Antitumor Medicine Sales () Forecast by Type (2017-2022)
Figure Japan Natural Source Antitumor Medicine Sales () Forecast by Type (2017-2022)
Figure Global Natural Source Antitumor Medicine Sales () Forecast by Type (2017-2022)
Figure Japan Natural Source Antitumor Medicine Sales Volume Market Share Forecast by Type in 2017
Figure Global Natural Source Antitumor Medicine Sales Volume Market Share Forecast by Type in 2017
Table Japan Natural Source Antitumor Medicine Sales () Forecast by Application (2017-2022)
Figure Japan Natural Source Antitumor Medicine Sales Volume Market Share Forecast by Application (2017-2022)
Figure Japan Natural Source Antitumor Medicine Sales Volume Market Share Forecast by Application in 2017
Table Global Natural Source Antitumor Medicine Sales () Forecast by Application (2017-2022)
Figure Global Natural Source Antitumor Medicine Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Natural Source Antitumor Medicine Sales Volume Market Share Forecast by Application in 2017
Table Japan Natural Source Antitumor Medicine Sales () Forecast by Regions (2017-2022)
Table Japan Natural Source Antitumor Medicine Sales Volume Share Forecast by Regions (2017-2022)
Figure Japan Natural Source Antitumor Medicine Sales Volume Share Forecast by Regions (2017-2022)
Table Global Natural Source Antitumor Medicine Sales () Forecast by Regions (2017-2022)
Table Global Natural Source Antitumor Medicine Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Natural Source Antitumor Medicine Sales Volume Share Forecast by Regions (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories